Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · IEX Real-Time Price · USD
10.89
+0.35 (3.32%)
May 20, 2024, 4:00 PM EDT - Market closed

Phathom Pharmaceuticals Statistics

Total Valuation

PHAT has a market cap or net worth of $637.45 million. The enterprise value is $764.93 million.

Market Cap 637.45M
Enterprise Value 764.93M

Important Dates

The last earnings date was Thursday, May 9, 2024, before market open.

Earnings Date May 9, 2024
Ex-Dividend Date n/a

Share Statistics

PHAT has 58.54 million shares outstanding. The number of shares has increased by 37.82% in one year.

Shares Outstanding 58.54M
Shares Change (YoY) +37.82%
Shares Change (QoQ) +1.76%
Owned by Insiders (%) 8.92%
Owned by Institutions (%) 90.31%
Float 43.28M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 245.74
Forward PS 8.20
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 294.88
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 7.83

Current Ratio 7.83
Quick Ratio 7.57
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -3.94

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -77.50%
Return on Capital (ROIC) -68.14%
Revenue Per Employee $5,739
Profits Per Employee -$545,642
Employee Count 452
Asset Turnover 0.01
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -19.21% in the last 52 weeks. The beta is 0.67, so PHAT's price volatility has been lower than the market average.

Beta (1Y) 0.67
52-Week Price Change -19.21%
50-Day Moving Average 9.84
200-Day Moving Average 9.80
Relative Strength Index (RSI) 60.47
Average Volume (30 Days) 781,182

Short Selling Information

The latest short interest is 11.80 million, so 20.15% of the outstanding shares have been sold short.

Short Interest 11.80M
Short Previous Month 12.03M
Short % of Shares Out 20.15%
Short % of Float 27.25%
Short Ratio (days to cover) 16.50

Income Statement

In the last 12 months, PHAT had revenue of $2.59 million and -$246.63 million in losses. Loss per share was -$4.47.

Revenue 2.59M
Gross Profit 2.00M
Operating Income -207.19M
Pretax Income -246.63M
Net Income -246.63M
EBITDA -196.07M
EBIT -196.71M
Loss Per Share -$4.47
Full Income Statement

Balance Sheet

The company has $325.10 million in cash and $452.57 million in debt, giving a net cash position of -$127.48 million or -$2.18 per share.

Cash & Cash Equivalents 325.10M
Total Debt 452.57M
Net Cash -127.48M
Net Cash Per Share -$2.18
Equity / Book Value -148.50M
Book Value Per Share -2.54
Working Capital 296.86M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$166.93 million and capital expenditures -$1.46 million, giving a free cash flow of -$168.39 million.

Operating Cash Flow -166.93M
Capital Expenditures -1.46M
Free Cash Flow -168.39M
FCF Per Share -$2.89
Full Cash Flow Statement

Margins

Gross margin is 77.14%, with operating and profit margins of -7,987.24% and -9,507.71%.

Gross Margin 77.14%
Operating Margin -7,987.24%
Pretax Margin -9,507.71%
Profit Margin -9,507.71%
EBITDA Margin -7,558.52%
EBIT Margin -7,583.31%
FCF Margin -6,491.56%

Dividends & Yields

PHAT does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -37.82%
Shareholder Yield -37.82%
Earnings Yield -38.69%
FCF Yield -26.42%

Analyst Forecast

The average price target for PHAT is $22.00, which is 102.02% higher than the current price. The consensus rating is "Strong Buy".

Price Target $22.00
Price Target Difference 102.02%
Analyst Consensus Strong Buy
Analyst Count 4
Revenue Growth Forecast (5Y) 310.52%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

PHAT has an Altman Z-Score of -4.03 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -4.03
Piotroski F-Score 1